首页 | 本学科首页   官方微博 | 高级检索  
     

参附注射液在危重症患者中的应用进展
引用本文:司向,管向东. 参附注射液在危重症患者中的应用进展[J]. 中华重症医学电子杂志, 2020, 6(1): 92-95. DOI: 10.3877/cma.j.issn.2096-1537.2020.028
作者姓名:司向  管向东
作者单位:1. 510080 广州,中山大学附属第一医院重症医学科
基金项目:吴阶平医学基金会临床科研专项资助基金(320.6750.18037, 320.6750.18068); 广东省科技计划项目(2017B020247002)
摘    要:参附注射液是我国传统医学和现代医学融合发展的结晶,随着近些年对其作用机制的不断探索及临床研究的逐渐深入,其适用范围不断拓展,尤其在救治急危重症患者中的有效性和安全性不断得到肯定,日益受到学者们的关注。本文就参附注射液的作用机制以及在危重症患者,特别是休克及心肺复苏患者中的应用进行综述,以期对将来基础医学和临床研究有所帮助。

关 键 词:参附注射液  重症  休克  心肺复苏
收稿时间:2019-12-10

Application of Shenfu injection in critically ill patients
Xiang Si,Xiangdong Guan. Application of Shenfu injection in critically ill patients[J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2020, 6(1): 92-95. DOI: 10.3877/cma.j.issn.2096-1537.2020.028
Authors:Xiang Si  Xiangdong Guan
Affiliation:1. Department of Critical Care Medicine, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510080, China
Abstract:The Shenfu injection(SFI)is the integration of Chinese traditional medicine and modern medicine.Recently,with the continuous exploration of its mechanism of pharmaceutical activity and the gradual deepening of clinical research,the application of SFI has been expanding.Especially in the treatment of critically ill patients,its effectiveness and safety has been constantly affirmed,and has attracted increasing attention of scholars.This article reviewed the mechanism of SFI and its application in critically ill patients,especially those with shock and cardiopulmonary resuscitation,in order to promote further basic medicine and clinical research in the future.
Keywords:Shenfu  Critical care  Shock  Cardiopulmonary resuscitation  
本文献已被 维普 等数据库收录!
点击此处可从《中华重症医学电子杂志》浏览原始摘要信息
点击此处可从《中华重症医学电子杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号